Vitrolife AB (publ) (LON: 0YAY)
London
· Delayed Price · Currency is GBP · Price in SEK 222.00
-12.60 (-5.37%)
At close: Jan 31, 2025
Vitrolife AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 3,609 | 3,512 | 3,234 | 1,681 | 1,246 | Upgrade
|
| Revenue Growth (YoY) | 2.76% | 8.60% | 92.39% | 34.96% | -15.85% | Upgrade
|
| Cost of Revenue | 1,470 | 1,534 | 1,454 | 635 | 477.91 | Upgrade
|
| Gross Profit | 2,139 | 1,978 | 1,780 | 1,046 | 767.67 | Upgrade
|
| Selling, General & Admin | 1,232 | 1,117 | 1,002 | 503 | 311.35 | Upgrade
|
| Research & Development | 117 | 127 | 143 | 114 | 91.76 | Upgrade
|
| Other Operating Expenses | 7 | -4 | -12 | - | -2.55 | Upgrade
|
| Operating Expenses | 1,356 | 1,240 | 1,133 | 617 | 400.56 | Upgrade
|
| Operating Income | 783 | 738 | 647 | 429 | 367.11 | Upgrade
|
| Interest Expense | -109 | -94 | -44 | -10 | -2.09 | Upgrade
|
| Interest & Investment Income | - | 16 | 2 | 1 | 0.76 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -64 | -34 | 41 | -16.79 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -5 | -16 | -1 | -0.37 | Upgrade
|
| EBT Excluding Unusual Items | 674 | 591 | 555 | 460 | 348.62 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 8.92 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -3 | -23 | - | -0.05 | Upgrade
|
| Asset Writedown | - | -4,300 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 8.7 | Upgrade
|
| Pretax Income | 674 | -3,712 | 537 | 460 | 366.19 | Upgrade
|
| Income Tax Expense | 160 | 139 | 143 | 116 | 78.33 | Upgrade
|
| Earnings From Continuing Operations | 514 | -3,851 | 394 | 344 | 287.87 | Upgrade
|
| Minority Interest in Earnings | -1 | - | - | -3 | -1.02 | Upgrade
|
| Net Income | 513 | -3,851 | 394 | 341 | 286.85 | Upgrade
|
| Net Income to Common | 513 | -3,851 | 394 | 341 | 286.85 | Upgrade
|
| Net Income Growth | - | - | 15.54% | 18.88% | -25.06% | Upgrade
|
| Shares Outstanding (Basic) | 135 | 135 | 135 | 115 | 109 | Upgrade
|
| Shares Outstanding (Diluted) | 136 | 135 | 135 | 115 | 109 | Upgrade
|
| Shares Change (YoY) | 0.09% | - | 18.12% | 5.60% | - | Upgrade
|
| EPS (Basic) | 3.79 | -28.44 | 2.91 | 2.97 | 2.64 | Upgrade
|
| EPS (Diluted) | 3.78 | -28.44 | 2.91 | 2.97 | 2.64 | Upgrade
|
| EPS Growth | - | - | -2.18% | 12.58% | -25.06% | Upgrade
|
| Free Cash Flow | 710 | 690 | 585 | 359 | 349.68 | Upgrade
|
| Free Cash Flow Per Share | 5.24 | 5.10 | 4.32 | 3.13 | 3.22 | Upgrade
|
| Dividend Per Share | 1.100 | 1.000 | 0.850 | 0.800 | 0.800 | Upgrade
|
| Dividend Growth | 10.00% | 17.65% | 6.25% | 0% | - | Upgrade
|
| Gross Margin | 59.27% | 56.32% | 55.04% | 62.22% | 61.63% | Upgrade
|
| Operating Margin | 21.70% | 21.01% | 20.01% | 25.52% | 29.47% | Upgrade
|
| Profit Margin | 14.21% | -109.65% | 12.18% | 20.29% | 23.03% | Upgrade
|
| Free Cash Flow Margin | 19.67% | 19.65% | 18.09% | 21.36% | 28.07% | Upgrade
|
| EBITDA | 1,225 | 1,107 | 991 | 506 | 420.88 | Upgrade
|
| EBITDA Margin | 33.94% | 31.52% | 30.64% | 30.10% | 33.79% | Upgrade
|
| D&A For EBITDA | 442 | 369 | 344 | 77 | 53.77 | Upgrade
|
| EBIT | 783 | 738 | 647 | 429 | 367.11 | Upgrade
|
| EBIT Margin | 21.70% | 21.01% | 20.01% | 25.52% | 29.47% | Upgrade
|
| Effective Tax Rate | 23.74% | - | 26.63% | 25.22% | 21.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.